Lantheus Holdings, Inc. (LNTH)
USD 89.5
(-1.56%)
USD 89.5
(-1.56%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 64.02 Million USD | 80.49% |
| 2022 | 35.47 Million USD | 0.98% |
| 2021 | 35.12 Million USD | -1.72% |
| 2020 | 35.74 Million USD | 22.49% |
| 2019 | 29.18 Million USD | -11.63% |
| 2018 | 33.01 Million USD | 26.61% |
| 2017 | 26.08 Million USD | 47.85% |
| 2016 | 17.64 Million USD | 12.92% |
| 2015 | 15.62 Million USD | 0.26% |
| 2014 | 15.58 Million USD | -14.9% |
| 2013 | 18.31 Million USD | 1.45% |
| 2012 | 18.04 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 69.75 Million USD | 8.95% |
| 2024 Q2 | 70.51 Million USD | 1.09% |
| 2023 FY | 64.02 Million USD | 80.49% |
| 2023 Q3 | 56.46 Million USD | 9.0% |
| 2023 Q4 | 64.02 Million USD | 13.4% |
| 2023 Q1 | 42.15 Million USD | 18.83% |
| 2023 Q2 | 51.8 Million USD | 22.88% |
| 2022 Q4 | 35.47 Million USD | 1.96% |
| 2022 Q2 | 33.95 Million USD | -0.85% |
| 2022 Q1 | 34.24 Million USD | -2.51% |
| 2022 FY | 35.47 Million USD | 0.98% |
| 2022 Q3 | 34.79 Million USD | 2.46% |
| 2021 FY | 35.12 Million USD | -1.72% |
| 2021 Q1 | 30.35 Million USD | -15.07% |
| 2021 Q2 | 31.71 Million USD | 4.49% |
| 2021 Q3 | 33.94 Million USD | 7.03% |
| 2021 Q4 | 35.12 Million USD | 3.48% |
| 2020 FY | 35.74 Million USD | 22.49% |
| 2020 Q1 | 30.81 Million USD | 5.6% |
| 2020 Q3 | 37.62 Million USD | 6.48% |
| 2020 Q4 | 35.74 Million USD | -4.99% |
| 2020 Q2 | 35.33 Million USD | 14.67% |
| 2019 Q2 | 32.41 Million USD | 1.15% |
| 2019 Q4 | 29.18 Million USD | -4.63% |
| 2019 FY | 29.18 Million USD | -11.63% |
| 2019 Q1 | 32.04 Million USD | -2.95% |
| 2019 Q3 | 30.59 Million USD | -5.61% |
| 2018 Q4 | 33.01 Million USD | -4.49% |
| 2018 Q1 | 32.08 Million USD | 23.03% |
| 2018 FY | 33.01 Million USD | 26.61% |
| 2018 Q2 | 31.47 Million USD | -1.91% |
| 2018 Q3 | 34.57 Million USD | 9.84% |
| 2017 Q4 | 26.08 Million USD | 13.23% |
| 2017 FY | 26.08 Million USD | 47.85% |
| 2017 Q3 | 23.03 Million USD | 8.89% |
| 2017 Q2 | 21.15 Million USD | 6.88% |
| 2017 Q1 | 19.79 Million USD | 12.19% |
| 2016 Q4 | 17.64 Million USD | 9.86% |
| 2016 FY | 17.64 Million USD | 12.92% |
| 2016 Q1 | 15.54 Million USD | -0.52% |
| 2016 Q2 | 14.43 Million USD | -7.13% |
| 2016 Q3 | 16.05 Million USD | 11.25% |
| 2015 Q3 | 16.57 Million USD | 7.68% |
| 2015 Q4 | 15.62 Million USD | -5.77% |
| 2015 Q2 | 15.39 Million USD | -4.69% |
| 2015 Q1 | 16.15 Million USD | 3.66% |
| 2015 FY | 15.62 Million USD | 0.26% |
| 2014 Q4 | 15.58 Million USD | -5.13% |
| 2014 FY | 15.58 Million USD | -14.9% |
| 2014 Q1 | 18.49 Million USD | 1.01% |
| 2014 Q2 | 16.3 Million USD | -11.86% |
| 2014 Q3 | 16.42 Million USD | 0.76% |
| 2013 FY | 18.31 Million USD | 1.45% |
| 2013 Q1 | 17.6 Million USD | -2.47% |
| 2013 Q3 | 17.03 Million USD | 3.71% |
| 2013 Q2 | 16.42 Million USD | -6.68% |
| 2013 Q4 | 18.31 Million USD | 7.47% |
| 2012 Q4 | 18.04 Million USD | 0.0% |
| 2012 FY | 18.04 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cosmos Health Inc. | 4.78 Million USD | -1236.986% |
| Safety Shot Inc | 1.86 Million USD | -3324.657% |
| Bright Green Corporation | - USD | -Infinity% |
| Embecta Corp. | 152.1 Million USD | 57.903% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 42.418% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -845.915% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | -98.036% |
| Dynavax Technologies Corporation | 53.29 Million USD | -20.152% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 2.429% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | -449.747% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 38.642% |
| PainReform Ltd. | - USD | -Infinity% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -1016.508% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -1016.508% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -7807.187% |
| Journey Medical Corporation | 10.2 Million USD | -527.366% |
| Alpha Teknova, Inc. | 11.59 Million USD | -452.26% |
| Procaps Group, S.A. | 96.83 Million USD | 33.877% |
| Theratechnologies Inc. | 6.06 Million USD | -955.539% |
| Harrow Health, Inc. | 10.86 Million USD | -489.206% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -2254.873% |
| Biofrontera Inc. | 10.9 Million USD | -486.991% |
| DURECT Corporation | 2.21 Million USD | -2785.489% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 17.284% |
| Cronos Group Inc. | 30.33 Million USD | -111.045% |
| OptiNose, Inc. | 8.05 Million USD | -695.194% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -6402899900.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -1023.506% |
| Organogenesis Holdings Inc. | 28.25 Million USD | -126.627% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -2291.719% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -1289.108% |
| Radius Health, Inc. | 278.64 Million USD | 77.021% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -1815.163% |
| ProPhase Labs, Inc. | 3.84 Million USD | -1566.988% |
| Phibro Animal Health Corporation | 265.91 Million USD | 75.921% |
| Procaps Group S.A. | 96.83 Million USD | 33.877% |
| Alvotech | 74.43 Million USD | 13.978% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 98.155% |
| Rockwell Medical, Inc. | 5.87 Million USD | -990.598% |
| Aytu BioPharma, Inc. | 12.63 Million USD | -406.839% |
| SIGA Technologies, Inc. | 64.21 Million USD | 0.295% |
| Tilray Brands, Inc. | 252.08 Million USD | 74.6% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | -60.157% |
| Shineco, Inc. | 1.58 Million USD | -3930.72% |
| PetIQ, Inc. | 159.3 Million USD | 59.808% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 42009.83% |
| Incannex Healthcare Limited | -10.01 Million USD | 739.331% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | -67.178% |
| Alimera Sciences, Inc. | 1.87 Million USD | -3307.61% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | -69.901% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -3875.991% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -1328.262% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -25073.382% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -516.85% |
| Hempacco Co., Inc. | 2.54 Million USD | -2418.221% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 13.978% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | -33.969% |
| Currenc Group, Inc. | 732.91 Thousand USD | -8636.259% |
| Kamada Ltd. | 87.74 Million USD | 27.03% |
| Indivior PLC | 141.79 Million USD | 54.845% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -13188.436% |
| Flora Growth Corp. | 8.5 Million USD | -652.574% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -25073.382% |
| Evolus, Inc. | 10.99 Million USD | -482.188% |
| HUTCHMED (China) Limited | 50.25 Million USD | -27.401% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 39.5% |
| Akanda Corp. | 1.28 Million USD | -4875.468% |